[1]
|
Chen, Z., Sun, B., Duan, Q., Xue, Y. and Chen, L. (2018) 3.0T Contrast-Enhanced Whole-Heart Coronary Magnetic Resonance Angiography for Simultaneous Coronary Artery Angiography and Myocardial Viability in Chronic Myocardial Infarction. Medicine, 97, e13138. https://doi.org/10.1097/md.0000000000013138
|
[2]
|
Kitkungvan, D., Lai, D., Zhu, H., Roby, A.E., Johnson, N.P., Steptoe, D.D., et al. (2017) Optimal Adenosine Stress for Maximum Stress Perfusion, Coronary Flow Reserve, and Pixel Distribution of Coronary Flow Capacity by Kolmogorov-Smirnov Analysis. Circulation: Cardiovascular Imaging, 10, e005650. https://doi.org/10.1161/circimaging.116.005650
|
[3]
|
彭安庆, 郑敏娟. 药物负荷超声心动图及新型腺苷类负荷药物的临床应用[J]. 中华医学超声杂志(电子版), 2024, 21(2): 183-186.
|
[4]
|
Go, A.S., Mozaffarian, D., Roger, V.L., et al. on Behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee (2013) Executive Summary: Heart Disease and Stroke Statistics-2013 Update: A Report from the American Heart Association. Circulation, 127, 143-152. https://doi.org/10.1161/CIR.0b013e318282ab8f
|
[5]
|
Gaziano, T.A., Bitton, A., Anand, S., Abrahams-Gessel, S. and Murphy, A. (2010) Growing Epidemic of Coronary Heart Disease in Low-and Middle-Income Countries. Current Problems in Cardiology, 35, 72-115. https://doi.org/10.1016/j.cpcardiol.2009.10.002
|
[6]
|
Judd, R.M., Lugo-Olivieri, C.H., Arai, M., Kondo, T., Croisille, P., Lima, J.A.C., et al. (1995) Physiological Basis of Myocardial Contrast Enhancement in Fast Magnetic Resonance Images of 2-Day-Old Reperfused Canine Infarcts. Circulation, 92, 1902-1910. https://doi.org/10.1161/01.cir.92.7.1902
|
[7]
|
Rochitte, C.E., Lima, J.A.C., Bluemke, D.A., Reeder, S.B., McVeigh, E.R., Furuta, T., et al. (1998) Magnitude and Time Course of Microvascular Obstruction and Tissue Injury after Acute Myocardial Infarction. Circulation, 98, 1006-1014. https://doi.org/10.1161/01.cir.98.10.1006
|
[8]
|
郭彩艳, 靳春荣. 腺苷药物在心血管疾病诊治中的应用进展[J]. 心血管病学进展, 2019, 40(7): 1011-1014.
|
[9]
|
Al-Saadi, N., Nagel, E., Gross, M., Bornstedt, A., Schnackenburg, B., Klein, C., et al. (2000) Noninvasive Detection of Myocardial Ischemia from Perfusion Reserve Based on Cardiovascular Magnetic Resonance. Circulation, 101, 1379-1383. https://doi.org/10.1161/01.cir.101.12.1379
|
[10]
|
Wolff, S.D., Schwitter, J., Coulden, R., Friedrich, M.G., Bluemke, D.A., Biederman, R.W., et al. (2004) Myocardial First-Pass Perfusion Magnetic Resonance Imaging. Circulation, 110, 732-737. https://doi.org/10.1161/01.cir.0000138106.84335.62
|
[11]
|
Giang, T., Nanz, D., Coulden, R., Friedrich, M., Graves, M., Alsaadi, N., et al. (2004) Detection of Coronary Artery Disease by Magnetic Resonance Myocardial Perfusion Imaging with Various Contrast Medium Doses: First European Multi-Centre Experience. European Heart Journal, 25, 1657-1665. https://doi.org/10.1016/j.ehj.2004.06.037
|
[12]
|
Greenwood, J.P., Maredia, N., Younger, J.F., Brown, J.M., Nixon, J., Everett, C.C., et al. (2012) Cardiovascular Magnetic Resonance and Single-Photon Emission Computed Tomography for Diagnosis of Coronary Heart Disease (CE-MARC): A Prospective Trial. The Lancet, 379, 453-460. https://doi.org/10.1016/s0140-6736(11)61335-4
|
[13]
|
中华医学会心血管病学分会影像学组, 中国医师协会放射医师分会心血管专业委员会. 无创性心血管影像学技术临床适用标准中国专家共识[J]. 中华心血管病杂志, 2020, 48(11): 906-921.
|
[14]
|
Hsiao, E., Ali, B., Blankstein, R., Skali, H., Ali, T., Bruyere, J., et al. (2013) Detection of Obstructive Coronary Artery Disease Using Regadenoson Stress and 82Rb PET/CT Myocardial Perfusion Imaging. Journal of Nuclear Medicine, 54, 1748-1754. https://doi.org/10.2967/jnumed.113.120063
|
[15]
|
Thomas, G.S., Tammelin, B.R., Schiffman, G.L., Marquez, R., Rice, D.L., Milikien, D., et al. (2008) Safety of Regadenoson, a Selective Adenosine A2A Agonist, in Patients with Chronic Obstructive Pulmonary Disease: A Randomized, Double-Blind, Placebo-Controlled Trial (RegCOPD Trial). Journal of Nuclear Cardiology, 15, 319-328. https://doi.org/10.1016/j.nuclcard.2008.02.013
|
[16]
|
Prenner, B.M., Bukofzer, S., Behm, S., Feaheny, K. and McNutt, B.E. (2012) A Randomized, Double-Blind, Placebo-Controlled Study Assessing the Safety and Tolerability of Regadenoson in Subjects with Asthma or Chronic Obstructive Pulmonary Disease. Journal of Nuclear Cardiology, 19, 681-692. https://doi.org/10.1007/s12350-012-9547-4
|
[17]
|
Husain, Z., Palani, G., Cabrera, R., Karthikeyan, A.S., Dhanalakota, S., Pathmanathan, S., et al. (2011) Hemodynamic Response, Arrhythmic Risk, and Overall Safety of Regadenoson as a Pharmacologic Stress Agent for Myocardial Perfusion Imaging in Chronic Obstructive Pulmonary Disease and Bronchial Asthma Patients. The International Journal of Cardiovascular Imaging, 28, 1841-1849. https://doi.org/10.1007/s10554-011-0003-3
|
[18]
|
Leaker, B.R., O’Connor, B., Hansel, T.T., Barnes, P.J., Meng, L., Mathur, V.S., et al. (2008) Safety of Regadenoson, an Adenosine A2A Receptor Agonist for Myocardial Perfusion Imaging, in Mild Asthma and Moderate Asthma Patients: A Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Nuclear Cardiology, 15, 329-336. https://doi.org/10.1016/j.nuclcard.2008.02.009
|